Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
Description
CONCLUSION: Despite the immunosuppression of patients with onco-hematological diseases, caused by the biology of their diseases and treatment, benefit and safety in vaccinating these patients are observed, in view of the important recall immune
